Is BioMarin Pharmaceutical Inc. (0HNC.L) a Buy, Sell, or Hold?
LSE : 0HNC.L
BioMarin Pharmaceutical Inc. — Competitors
$59.31 USD
$1.27 (2.19%)
- Volume
- 181
- Average Volume
- 5.97K
- Market Capitalization
- $10.56B
- P/E Ratio
- 42.38
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $99.65
- Year Low
- $58.89
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.81
0HNC.L vs. The Competition
| Properties | 0HNC.L | 0HCK.L | 0HKF.L | 0I3Q.L |
|---|---|---|---|---|
| Market Cap | $10.56B | $12.08B | $12.12B | $9.95B |
| Shares Outstanding | $178.06M | $71.62M | $50.33M | $103.95M |
| P/E Ratio | 42.38 | 27.98 | -64.61 | 211.91 |
| EPS | 1.4 | 6.02 | -3.68 | 0.46 |
| Day Low | 58.89 | 165.1 | 237.99 | 95.01 |
| Day High | 59.64 | 172.75 | 243.56 | 99.99 |
| Year Low | 58.89 | 165.1 | 55.64 | 20.76 |
| Year High | 99.65 | 411.5347 | 243.56 | 99.99 |
| Average Price 50 | 90.32232 | 287.8779 | 85.35423 | 23.44245 |
| Average Price 200 | 89.60658 | 293.63324 | 75.30271 | 26.00163 |
| Volume | 181 | 141 | 1359 | 167 |
| Average Volume | - | - | - | - |